רווח לפני תשלום ריבית, מסים ופחת: Allurion (ALUR)

Compliance with environmental assembly standards is driving growth, as evidenced by the operating profit trend, where the current figure stands at 0.00. The foundation of Allurion Technologies (ALUR) success is based on unique patents and strict FDA control. The innovative non-contact balloon for weight loss, combined with a digital service, radically simplifies the obesity therapy process.

This indicator measures real cash flow from core operations before depreciation and taxes, allowing for the exclusion of accounting adjustments to assess the real-time fundamental stability of the business. By analyzing the cash volume of EBITDA, an investor can see how global demand for Allurion Technologies (ALUR) balloons generates cash, which is currently offset by high operational development costs.